Dansaert SRL
1.5 FTEThe score of Dansaert shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +156 % Total assets +115 % Headcount (avg FTE) -40 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dansaert's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Sep 2026
- Year ended 31 Dec 2024filed on 29 Sep 2025
- Year ended 31 Dec 2023filed on 30 Sep 2024
- Year ended 31 Dec 2022filed on 05 Oct 2023
- Year ended 31 Dec 2021filed on 14 Oct 2022
Dansaert's financial analysis
- Solvency89.3%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dansaert
Dansaert's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0458.664.894
- VAT number
- BE0458664894
- Peppol
- Registered · 0208:0458664894 · as of 05 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Aug 1996
- Registered office
- 1000 Brussels
- Size
- Micro · 1.5 FTE
- Latest accounts
- 2025 · filed on 29 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Dansaert (SRL) has been based in Brussels since 1996, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of €1.29m and equity of €3.51m; its revenue is not published. With 1.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 89.3%, above the median of its sector (37.8%).
Companies similar to Dansaert
Companies in the same business, of comparable size and area, outside its group.
- Alpaga MDB Retail sale of pharmaceutical products Kontich · balance sheet €5.32m
- Apotheek Leroy Retail sale of pharmaceutical products Antwerp · balance sheet €4.03m
- Hainapharma Retail sale of pharmaceutical products Aiseau-Presles · balance sheet €4.03m
- Patrimanne Retail sale of pharmaceutical products Stekene · balance sheet €3.82m
- Pharmacie Libert Retail sale of pharmaceutical products Charleroi · balance sheet €4.11m
- Remopharma Retail sale of pharmaceutical products Sint-Gillis-Waas · balance sheet €3.66m
- DE Maeyer - DE Ryck Retail sale of pharmaceutical products Wommelgem · balance sheet €3.62m
- Tornaphar Retail sale of pharmaceutical products Tournai · balance sheet €3.74m
Frequently asked questions about Dansaert
What is the revenue of Dansaert?
Dansaert files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dansaert?
In Belgium, the VAT number is the company number prefixed with BE: BE0458664894 for Dansaert, if the company is VAT-registered. Its company number (CBE) is 0458.664.894.
Where is the registered office of Dansaert?
According to the CBE register, the registered office of Dansaert is in 1000 Brussels.
What is the equity of Dansaert?
At the close of the 2025 financial year, the equity of Dansaert amounts to 3,509,440 €, a solvency of 89.3% of total assets.
How many people work at Dansaert?
1.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Dansaert?
The register lists 1 active mandates at Dansaert. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dansaert
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →